CompletedPHASE2, PHASE3NCT01206270
Androgen for Leydig Cell Proliferation
Studying Sex chromosome difference of sex development
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Roma La Sapienza
- Principal Investigator
- Andrea Lenzi, MD, MDUniversity of Roma La Sapienza
- Intervention
- Testosterone undecanoate(drug)
- Enrollment
- 56 enrolled
- Eligibility
- 18-60 years · MALE
- Timeline
- 2009 – 2018
Study locations (1)
- Dipartimento di Fisiopatologia Medica, Rome, Lazio, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01206270 on ClinicalTrials.govOther trials for Sex chromosome difference of sex development
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07142135Long-term Systematic Follow-up of Patients With Klinefelter Syndrome Followed at the Department of Growth and Reproduction, RigshospitaletRigshospitalet, Denmark
- RECRUITINGPHASE4NCT06294990Klinefelter Syndrome and Testosterone Treatment in PubertyLise Aksglæde
See all trials for Sex chromosome difference of sex development →